CTS - NYSE

Good morning and a warm welcome to the CTS Corporation Second Quarter 2023 Conference Call. My name is Candice and I will be your moderator for today's call. [Operator Instructions] I would now like to turn the call over to our host Kieran O'Sullivan. Please go ahead.

Thank you, Candice. Good morning and thank you for joining our second quarter 2023 earnings call. We posted solid quarterly results and had strong new business wins, including robust electrification bookings where we obtained our first award for our innovative eBrake product. We also continue to expand our customer base in medical and industrial markets. Our focus on profitable growth driving diversification through our advanced materials capability and growth through electrification in mobility markets with innovative new products remain our highest priorities. We are energized by the significant awards in the quarter and remain focused on achieving our long-term strategic goals while improving our operational performance. For the second quarter 2023, sales were $145 million, essentially flat compared to the same period last year. Adjusted gross margin was 35%, down 120 basis points from the same period in 2022, driven primarily by the mix shift to transportation products. We expect this mix shift to persist for a few more quarters. Adjusted diluted earnings per share was $0.59, down $0.03 compared to the second quarter of 2022. New business awards were stellar in the quarter. Total booked business in transportation increased by $70 million to $1.6 billion. We also added 10 new customers across different end markets. I just mentioned the first eBrake product award, a significant strategic milestone as we capture growth opportunities through the electrification megatrend. Our Maglab team had a notable win and also secured a reference design award with a semiconductor OEM. Ashish will now take us through the Safe Harbor statement. Ashish?

I would like to remind our listeners that this conference call contains forward-looking statements. These statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements. Additional information regarding these risks and uncertainties is contained in the press release issued today and more information can be found in the company's SEC filings. To the extent that today's discussion refers to any non-GAAP measures under Regulation G. The required explanations and reconciliations are available in the Investors section of the CTS website. I will now turn the discussion back to our CEO, Kieran O'Sullivan.

Thank you. Ashish. Overall, we achieved solid results in the quarter as we managed through challenging market dynamics in non-transportation markets, driven primarily by higher inventory levels at our customer. Sales were $145 million, essentially flat from the same period last year. Organic sales, which exclude sales from the recent acquisitions were down 4.4% for the quarter, driven primarily by the burn down of inventory in distribution and with industrial customers. Customer demand remained soft in certain markets in the quarter and we expect this trend to continue in the second half of the year for non-transportation sales. In the short term, we expect transportation sales to outpace non-transportation sales impacting margin performance. Inflationary impacts though improving in some areas, continues to be a challenge and we are adjusting pricing in partnership with our customers. We are continuing to prioritize our organic growth projects and prudently manage operational expenses throughout this time. Operationally, we are driving improvements to enhance our gross margin performance. Work is progressing on the previously announced site consolidations. Denmark is now substantially complete and the Mexico transition will be completed next year. With a reduced volume, we continue to focus on cost reductions. And as previously communicated, we will have some temporary cost increases as we complete our Mexico site consolidation. We continue to implement our CTS operating system across the organization. We seek to deploy capital and appropriate M&A to further enhance our growth prospects in line with our strategic plans for diversification, electrification, and channel growth. The integration of the Maglab acquisition is proceeding well and we recently finalized a relationship with a semiconductor partner for advanced product development for an electric vehicle application. We added 10 new customers in the quarter. One is defense, five in industrial, and four in medical. We had strong new business awards, especially in electrification bookings, and an expanding future customer base in non-transportation markets. Highlighting near-term and long-term growth trends, we had a book-to-bill rate in the quarter of 0.98 and our total book of business for transportation was at $1.6 billion, up from $1.5 billion at the end of the first quarter of 2023. Non-transportation sales declined 10% in the second quarter compared to the prior year period. In the industrial market, demand for microactuators used in industrial printing applications has remained soft, and we're also seeing softness across temperature sensing and distribution as inventory levels correct. We were successful with sales wins across temperature sensing for HVAC and RF filters for use in industrial and tenant and EMC applications. We added five new customers with applications in data transfer for oil and gas, oceanic climate temperature monitoring, flow metering, and accelerometers used in preventative maintenance. Also of significance, our recently added Maglab team was successful in winning a current sensing award for a broadband telecom application. In medical markets, we see good momentum. We had multiple wins in the quarter for traditional medical ultrasound, temperature sensing, and sensing controls. Our targeted business development efforts are progressing as we added four new customers across multiple applications, including therapeutics, health monitoring, laser control, and minimally invasive sensors. We see solid momentum going forward with existing and new customers and continued expansion into new applications. We remain confident in the long-term prospects for the aerospace and defense end market given our enhanced capabilities and attractive new material formulations. We received multiple orders in the quarter for defense sonar applications and RF filters. Across aerospace, we had wins with applications for gyroscopes and temperature sensing. We are working with a new customer for an application in GPS anti-jamming. We continue to leverage the Ferroperm acquisition as we develop new material formulations for defense in Europe and North America and are testing new applications. Looking ahead for the rest of 2023, in non-transportation end markets, we expect continued softness in the industrial end market and distribution as customer inventory levels are normalized For defense and medical markets, we anticipate good growth and solid prospects, which we believe will continue to enhance our strategic diversification plans. Longer term, we expect our material formulations and in-house know-how to continue to support our growth in key high-quality non-transportation end markets in line with our diversification strategy. Additionally, we aim to continue expansion in these markets as we capitalized on the megatrends of automation, connectivity, and efficiency, as well as growth in minimally invasive medical procedures. Transportation sales improved in the second quarter. Sales were up 10% from the prior year period. We anticipate automotive demand to be up close to mid-single digits for 2023. We are tracking market share dynamics in China, given the competition between local and transplant OEMs. In the second quarter, we had strong wins across all product categories and all regions with both OEMs and Tier 1 customers. In accelerator modules, we secured our first award with a European OEM for the new modular accelerator pedal and had wins with existing OEMs in Europe, Asia, and North America. Across the sensor portfolio, we had Chassis Ride Height awards with European and North American OEMs and passive safety sensor wins with Tier 1 customers in both North America and Europe. Total booked business improved from $1.5 billion at the end of the first quarter to $1.6 billion. We are driving to achieve our goal of having more than 25% of our light vehicle revenue come from electrified platforms by 2025. Progress on securing electric vehicle business continued as we added 13 electric vehicle wins in the quarter. Importantly, we want to highlight the first award for eBrake, a significant strategic accomplishment that initiates a new growth platform for our company. As we look to our future, we are excited by the opportunity, the transition to electrification offers us. We see the footwell in the vehicle as a space where we expect to expand our product offering with traditional accelerator modules, new eBrake products, offering weight and cost advantages, and the future introduction of our Drive-Pad technology, a low travel vehicle velocity control product that simplifies the driver interface and increases the footwell design flexibility for our customers. We expect these and other sensor applications will increase our ability to grow content with a potential SAM of greater than $1 billion. Summarizing our outlook for the full year 2023, we expect the transportation market to be up single-digits. Looking at the North American light vehicle transportation market, the SAAR is expected to be in the 15 million unit range for 2023. European production is forecasted in the 16 million unit to 17 million unit range. China volumes are expected in the 26 million unit range and slightly down year-over-year. The commercial vehicle market remains solid. For non-transportation markets in line with our diversification strategy, we aim to expand the customer base and the range of applications in the industrial, medical, and defense end markets. Inventory levels continue to correct to more normal levels, especially in certain industrial applications and in distribution. We estimate this demand softness to remain at reduced levels in the second half. Demand in defense and medical markets is expected to remain solid. In terms of guidance for full year 2023, we previously communicated that we expected results to trend closer to the lower end of our issued guidance of sales in the range of $580 million to $640 million and adjusted diluted earnings per share in the range of $2.40 to $2.70. Given the anticipated continued softness in distribution and the industrial end market during the second half of the year, we are now updating the guidance for sales in the range of $565 million to $585 million and adjusted diluted earnings per share in the range of $2.20 to $2.40. Now, I'll turn it over to Ashish, who will walk us through the financial results in more detail.

Thank you, Kieran. Second quarter sales were $145 million, essentially flat compared to the second quarter 2022. Sales excluding acquisitions were down 4.4% compared to the second quarter of last year. Foreign currency exchange rates impacted revenue unfavorably by approximately $1.1 million. Sales to the transportation end market increased 10% year-over-year, reflecting recovery in the market and from supply chain issues resolved in the first quarter. Sales to other end markets declined by approximately 10% year-over-year. Due to the inventory reduction-related slowdown, primarily in distribution and the industrial end market. Our recent acquisitions, Ferroperm, TEWA, and Maglab performed well during the quarter, expanding our capabilities in several key end markets. Our adjusted gross margin was 35% in the second quarter, down 120 basis points compared to the second quarter of 2022. As expected, we were impacted unfavorably by the mix of end markets. We see this as a temporary challenge for the next few quarters. Foreign currency exchange rates also impacted gross margin unfavorably by approximately $1.7 million. As Kieran highlighted, we'll continue our focus on operational efficiency with the goal to improve gross margins and operating costs. In the second quarter, we reported earnings of $0.41 per diluted share. Adjusted earnings were $0.59 per diluted share compared to $0.62 per diluted share in the same period last year. During the quarter, we recorded approximately $0.03 in one-time benefit from certain tax items. We expect our tax rate for the full year to be in the range of 20% to 23% excluding discrete items. Next discussing our cash flow and balance sheet, we generated $23.4 million in operating cash flow during the second quarter of 2023. Free cash flow was $19.5 million as we focus on carefully managing capital expenditures. Year-to-date, operating cash flow was $35 million and free cash flow was $26 million. Controllable working capital was 18.4% compared to 17.7% in the second quarter of last year. As we mentioned in April, we are transitioning from our Juarez facility with activity picking up in the second half of 2023. During this period, we will build up some buffer stock to facilitate the transition. Our goal is to work through that safety stock quickly in 2024. In the second quarter, we repurchased 198,000 shares of CTS stock for approximately $8.8 million. In total during the quarter, we returned approximately $10 million to shareholders through buybacks and dividends. Year-to-date, we have returned $20.1 million to shareholders through buybacks and dividends. Sustaining a strong balance sheet continues to be a priority. We had a cash balance of $151 million at the end of June 2023, up from $144 million in March 2023, supported by stronger operating cash flow in the second quarter. Our long-term debt balance was $77 million on our $400 million facility, down from $80 million in the first quarter of 2023. Our strong balance sheet and cash flow generation position us well to support strategic acquisitions to propel our growth. This concludes our prepared comments. We would like to open the line for questions at this time.

[Operator Instructions] So our first question comes from the line of Justin Long of Stephens. Your line is now open. Please go ahead.

Thanks and good morning.

Good morning, Justin.

Hi, Justin.

So, maybe to start with a question on the guidance, as we think about the second half of the year, is there any additional color you can provide on the quarterly cadence of revenue and earnings as we think about the third quarter versus the fourth quarter? I'm curious if you're expecting those two quarters to look pretty similar or if there is a reason we should see either an improvement or a moderation in the year-end.

Justin, I'll start with the sales, Ashish, you can comment on the profitability. We're seeing some softness, Justin, as we talked about at the end of the first quarter and that softness has continued, and obviously, you can see across the industrial end market were down considerably to the softest point and we'll see a little bit more softening into the third quarter and maybe an improvement in the fourth quarter. But just to give you some context on that, if I look at a few different areas, the distribution side of it, we've had an inventory buildup there. We've seen minimal correction and we think that's going to take two more quarters to fully correct. We talked in the prepared comments about the microactuators for industry of printing and that's impacted by softness in China, and then we have other products like pool and spa and entertainment products that are closer to the consumer and we've seen more softness there. And I think the overall backdrop in China overall is a little concerning too. So that's probably a good way of giving you a picture as we go into the second half of the year.

Okay, helpful. And maybe a follow-up from an earnings perspective, just given this cyclical weakness is lasting a little bit longer than you anticipated, are there any cost actions that you're taking to help mitigate some of this topline pressure? And I guess when you put it all together, any thoughts on how gross margins progress in the back half, do you think we can stay relatively stable with second quarter levels or will we see additional pressure?

So, Justin, those are good questions. If you look at our overall numbers, we absorbed - I'm addressing the cost point first and then I'll come to gross margin. If you look at the SG&A, R&D expenses, we are continuing to invest in R&D. Kieran talked about several new product wins that we've had including eBrake that we want to continue investing in. On the SG&A side, the business is doing reasonably well to manage cost We have absorbed a few acquisitions and still year-over-year cost is in reasonably good shape, especially given the decline in revenue we have been focusing heavily on managing operating expenses. On the gross margin side, we will follow a little bit of the trend that Kieran highlighted on the revenue side, and our plans, our business leaders, they remain focused on driving operating efficiency as much as we can give the tough backdrop of revenue that we are working our way through at the moment. I would not expect anything materially different between Q3 and Q4 other than following the revenue trends.

And Justin, just going back to the top line sales, just a few other points, we feel really good about medical and also industrial and defense, good trends there. Transportation obviously is picking up from last year. We had a little bit of pickup as well in the second quarter from the supply shortage and - but we feel good overall. And even though we've got some softness here with customer inventory, we feel good about the fundamentals of the business and really encouraged by the strong wins we had in the quarter, especially as Ashish mentioned on that eBrake product line as well for the future.

Great. That's all helpful. And one last quick one, I was wondering if you could give an update on the acquisition pipeline and the valuation trends that you've seen in the market, curious if there's any change on that front.

Yes, Justin, we've got a healthy balance sheet and with the cash generation, we're looking to deploy that capital, and haven't seen significant shifts in valuations, but we're obviously always working our pipeline as part of our diversification and electrification strategy and we will be sure to keep the focus there too.

Got it. Thanks for the time.

Thanks, Justin.

Thank you. Our next question comes from the line of John Franzreb of Sidoti. Your line is now open, please go ahead.

Good morning, Kieran and Ashish. Thanks for taking the questions. I'd like to go back to the change in revenue guidance. What changed so meaningfully in the industrial markets that you didn't see a quarter ago and see now?

Probably the best way of describing that John is, as we saw the inventory buildup, we didn't see that positive inflection where it would tell us that we're hitting the bottom, so those markets have remained soft, and with the current inventory levels that we're aware of, we see that softness continuing into the third and fourth quarters. We may see a small inflection in the fourth quarter but it definitely feels appropriate to balance it this way.

John, one thing I want to - highlight is that - sorry, go ahead.

No, you're more important, you speak Ashish.

I was just going to call out that we did mention that we were expecting revenue to be closer to the lower end of our guidance range, so yes, we have had to adjust it further, but - that would be important to keep in the back of our heads as well.

I was just curious if it was like you seeing worse in the industrial print as you just talked about or HVAC or construction equipment or any of the sub-sectors of Industrial, I was wondering one of them stood out more than the other.

No, there is a blend of things there. I think the one that probably stands out a little bit to us is just that China backdrop in terms of the impact there. It's been softer than we expected.

Got it, got it. And can you talk a little bit about the transportation market? How much was it of second quarter revenue and how do you see that playing out for the balance of the year being total revenue for the full year?

John, could you ask your question again?

Transportation sales, what percentage of revenues were they in the second quarter? And what percentage of revenue do you expect them now to be in your full-year guidance?

So transportation was about 50% - a little over 55%. I think it was 56% of second quarter revenues. And as Kieran mentioned, there was a little bit of recovery from our supply chain issue, which helped second quarter sales. During the year, John, we haven't really specifically called out what the transportation share would be, but what I would expect based on the comments that Kieran also just mentioned, we are expecting transportation to be more stable through the rest of the year and we are expecting industrial distribution, that softness to continue through the end of the year. So that will give you some things to take into account as you look at the mix.

And John, as we talk about diversification as part of our strategy, obviously, that transportation numbers kicking up a little bit here short-term with some end market softness in industrial and we think in a few quarters that will correct.

Okay. And I guess I'm switching gears again here. When you talk about the new product awards, I'm curious about how long we're looking at your non-transportation markets to turn from award to revenue, particularly I guess the medical, maybe aerospace and defense a little bit longer-tail, but medical and industrial markets, what's the turnaround from order to revenue there. If you could give little color there, that would be helpful.

Yes, it typically depends on the product line and the end market. The development period can be 12 months to two years the max, usually in between, but the more important thing, John, is when it comes to the likes of medical, it's a step up year-over-year because it's a very slow evolving market and then it steps up and then it's sticky for a long period of time, so it takes a while with all the qualifications with the customers as you can imagine.

Yes, John, just keep in mind the new customers, the 10 new customers that we called out, we would report them based on POs that we have received from them. They will be relatively small volumes to start with and then ramp up as Kieran mentioned.

All right. One last question, I'll get back into queue. You mentioned something about inflation and price adjustments. What market are you seeing the most impact on inflation and where you're getting those price adjustments in?

We're seeing inflation right across the board and we've seen a little bit of correction in some cases, but we still seen continued inflation, John, and we're talking to all customers in all markets on pricing.

Okay, guys, thanks. I'll get back in the queue.

All right. Thanks, John.

Thank you. Our next question comes from the line of Joshua Buchalter of TD Cowen. Please go ahead, your line is now open.

Hi, guys, good morning, thank you for taking my question. I guess I wanted to follow up on that last question first. So were there any changes intra-quarter I guess as it seems like you unveiled there was more inventory in the channel that needed, did that impact pricing at all and has there been any changes in the pricing environment and your ability to pass on the input costs, I guess over the last three months? Thank you.

No, Joshua, I see - I don't see the inventory and the pricing connected directly at all. We're just working through that burn down, outside of that we're having those discussions on pricing, where we have the pressure points.

Got it, okay. So, it's really mix that's driving the margins lower and not so much anything in the pricing environment as you're seeing it.

Correct. And we would be very careful in terms of where we had pricing we've brought inventory at a higher level. We'd be very careful to make sure we're not absorbing that inventory increase.

Okay, understood. Thank you. And then it sounds like things did move I guess more than you expected intra-quarter, can you speak to your confidence of how you're managing your factory loadings and confidence in your ability to get the channel into a healthy spot, I guess, exiting this year and get back to normal growth into 2024. Thank you.

So, Josh, that is something that we're watching very carefully, the inventory levels as Kieran mentioned in the distribution channels as well as several of our industrial customers. The expectation is that it will take a couple of quarters for the inventory to correct. Having said that, we have highlighted that same thing in the past two earnings calls, it's taken longer than we anticipated but we do feel that it will take at least another couple of quarters to normalize before we get back to normal state.

And the other thing, Josh, that I would mention there is that even with these customers with inventory, we're out there working on new products in the pipeline, things we need to do to advance our growth beyond the second half softness, we feel good about the fundamentals of the business.

Got it. Thank you. Last question, congrats on the eBrake win, anything you can give us on I guess timing or magnitude of when that can layer into the model? Thank you and congrats.

Yes, Josh, that one is obviously a transportation product, it takes a little bit of development time, so we would expect that product to - first shipments to start in 2027 and revenue to be evident then. And as I've mentioned in the prepared comments, that's the first step forward in this market, which we see as a new growth platform for us. So we would be feeling very good about adding future customers in the future and growing that. Early stages of that revenue profile over several years could be in the $10 million range - $5 million to $10 million range.

I appreciate the color. Thank you.

Thank you. Our next question comes from Hendi Susanto from Gabelli Funds. Your line is now open, please go ahead.

Thank you. Good morning, Kieran and Ashish. My first question, you mentioned inventory correction may take a few quarters, how should we anticipate the shape of market recovery once inventory correction ends, do you anticipate that V shape recovery once that inventory correction has been completed?

I don't know about a V-shape recovery, what I would say is, we want to make sure we get to that positive inflection points and get back to more normal growth that we've seen in the non-transportation market, where we've had healthy high-single-digit or double-digit growth but obviously not in the next two quarters.

I see, and then Kieran, congratulation on the first win of eBrake. May I know what kind of select product placement or like strategy in your eBrake, like will it start from the premium vehicles going to more like midstream markers or like where are the market opportunities in eBrake across like different types of platforms?

So Hendi, first of all, I think our team did a great job. They've been working this strategy for a number of years to get this product to market, so kudos to the team. And then the other side of it is, our customers when we get into these breakthrough technologies don't like us giving us too much information on it, but needless to say, over time, we see this just like the accelerator module penetrating deeply into the marketplace, so we feel confident in terms of the direction of this and it's got some compelling reasons for our customers to move in this direction.

Thank you, Kieran. Thank you, Ashish.

Thank you, Hendi.

Thank you, Hendi.

Thank you. We now have a follow-up question from John Franzreb of Sidoti. Please go ahead, your line is now open.

Just a follow up on Hendi's question. I guess, in general, the EV strategy, you talked about the revenue opportunity, but is there a gross margin opportunity or is it just all revenue and straight similar gross margins?

John, obviously, we feel confident in terms of the initial steps forward here on the revenue side of it. And gross margin, I would just tell you that automotive is competitive. It's hard to say you're going to be above market long term. Initially, there's always challenges launching a product, so I just want to be careful here, right? I prefer to keep it much more in line with how we've historically performed.

Okay, fair enough. And one of the other questions was about the cadence of the revenue, is there a reason I wouldn't think that your fourth quarter wouldn't be seasonally weaker than the third quarter or is there orders that have been pushed back for delivery into the fourth quarter? I'm just not thinking about or don't recognize.

John, we generally don't have a significant amount of seasonality in the fourth quarter. We do see some towards the tail end of the year because of the holidays, but overall, during the quarter it's not a material level of seasonality. Having said that, as Kieran highlighted, we do expect maybe later in 2023 some level of recovery starting to show itself in the industrial end market and potentially in distribution as well as inventory levels normalize.

Great, thanks for clearing that up, Ashish. Thanks for taking my follow-ups, guys.

Thank you, John.

You're welcome.

Thank you. As there are no additional questions at this time, I'd like to hand the conference call back over to Kieran O'Sullivan for closing remarks.

Thank you, Candice, and thank you all for your time. CTS is well-positioned for future growth, driven by the megatrends of increased automation, connectivity, and energy efficiency. Overall, we are energized and focused on our long-term goals to drive profitable growth and improve operational performance. The strong wins in the quarter and expansion of new customers underline our confidence in the future and our ability to deliver on our strategic plans around electrification and diversification, supporting long-term profitable growth. I want to thank our global teams for their support and driving our strategic initiatives and the robust wins this past quarter. We also continue to work hard to enhance our operational performance. Thank you for joining us today this concludes our call.